advertisement
11.3.3 Apraclonidine, brimonidine (10)
Showing records 1 to 10
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine8834 The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial
Übeyt Inan Ü; Samet Ermis S; Yücel A; Öztürk F
Acta Ophthalmologica Scandinavica 2003; 81: 155-160
8586 Dorzolamide x apraclonidine in the prevention of the intraocular pressur spike after Nd:YAG laser posterior capsulotomy
Arieta CEL; Amaral MS; Matuda E; Crosta C; De Carvalho Moreira Filho D; Kara José N
Current Eye Research 2002; 25: 237-241
8484 A paradoxical ocular effect of brimonidine
Mushtaq B; Sardar J; Matthews TD
American Journal of Ophthalmology 2003; 135: 102-103
8483 Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology 2003; 110: 615-624
8774 The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Archives of Ophthalmology 2003; 121: 453-457
8812 A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%
Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 499-506
8622 Ocular perfusion pressure and visual field index modifications induced by alfa-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration: an acute study on primary open-angle glaucoma patients
Costagliola C; Parmeggiani F; Ciancaglini M; D'Oronzo E; Mastropasqua L; Sebastiani A
Ophthalmologica 2003; 217: 39-44
8486 Effect of single and multiple doses of 0.2% brimonidine tartrate in the glaucomatous beagle
Gelatt KN; MacKay EO
Veterinary Ophthalmology 2002; 5: 253-262
8696 The effect of brimonidine on postoperative hypertony after an extracapsular cataract extraction
Katsimpris JM; Petropoulos IK; Voros G; Gerodimos G; Pharmakakis NM
Journal Français d'Ophtalmologie 2003; 26: 369-374
8754 A 3-month comparison of efficacy and safety of brimonidine-Purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
Mundorf T; Williams R; Whitcup S; Felix C; Batoosingh A
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 37-44
